Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Encarnita Raya Ampil"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
The dementia epidemic, attributed to aging populations, represents a growing socio-economic burden. It is estimated that in 2019 about 55 million people worldwide were living with dementia. With many possible causes of dementia and the possibility of
Externí odkaz:
https://doaj.org/article/81a560cb7614468bb6a4a8699503d40b
Publikováno v:
Alzheimer's & Dementia. 17
Autor:
Nagaendran, Kandiah, Yee Fai, Chan, Christopher, Chen, Darwin, Dasig, Jacqueline, Dominguez, Seol-Heui, Han, Jianping, Jia, SangYun, Kim, Panita, Limpawattana, Li-Ling, Ng, Dinh Toan, Nguyen, Paulus Anam, Ong, Encarnita, Raya-Ampil, Nor'izzati, Saedon, Vorapun, Senanarong, Siti, Setiati, Harjot, Singh, Chuthamanee, Suthisisang, Tong Mai, Trang, Yuda, Turana, Narayanaswamy, Venketasubramanian, Fee Mann, Yong, Yong Chul, Youn, Ralf, Ihl
Publikováno v:
CNS Neuroscience & Therapeutics
Background Mild cognitive impairment (MCI) is a neurocognitive state between normal cognitive aging and dementia, with evidence of neuropsychological changes but insufficient functional decline to warrant a diagnosis of dementia. Individuals with MCI
Publikováno v:
Pharmaceutical Sciences Encyclopedia
Dementia, particularly Alzheimer's disease (AD), is increasing by patient population included in clinical trials. The methodology for trials of AD patients have been defined in terms of outcomes, standard measures and analytic techniques. Trial metho
Dementia is a health problem affecting millions of people worldwide. Its prevalence increases with age and it is almost always a disease of the elderly. It has also been observed that Alzheimer's disease (AD) is the leading cause of dementia. This ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cef21fd7b22490de036e3ac6ad8093b
https://doi.org/10.1002/9780470571224.pse228
https://doi.org/10.1002/9780470571224.pse228